Heart 1997;78:544-549 ( December )

Patterns and costs of hospital care for coronary heart disease related and not related to diabetes

C J Currie,^a C L Morgan,^b J R Peters^b

^a Department of Public Health Medicine, Bro Táf Health Authority, Cardiff, UK, ^b Department of Medicine, University Hospital of Wales, Cardiff, UK

Correspondence to: Dr Peters, Consultant Physician, University Hospital of Wales, Heath Park, Cardiff CF4 4XW, UK. email: wmdcjc{at}cf.ac.uk

Accepted for publication 2 July 1997

ObjectiveTo describe the epidemiology and costs of coronary heart disease (CHD) requiring hospital admission, with particular reference to diabetes.
SettingThe former South Glamorgan Health Authority, South Wales.
MethodsRoutine hospital activity data were record linked and all diabetic and non-diabetic individuals over a four year period (1991-95) were identified. A cost weight was included for each admission based on diagnosis related groups.
ResultsThere were 10 214 patients admitted with a primary diagnostic code for CHD, representing an incidence of 6.3 per 1000 per annum. Including all CHD and non-CHD admissions, these individuals were responsible for 17% of acute inpatient activity. Men had a consistently higher age specific prevalence of CHD than women. The age adjusted relative risk of CHD for patients with diabetes compared with those without was 4.1 for men and 5.5 for women. Patients with diabetes accounted for 16.9% of CHD related admissions and had a fourfold increased probability of undergoing a cardiac procedure. The total cost of CHD was estimated to be 6% of NHS revenue at 1994-95 pay and prices. Patients with diabetes were responsible for 16% of this expenditure. This translated to an estimated NHS acute hospital expenditure for CHD of £1.1 billion per year at 1994-95 pay and prices.
ConclusionsCHD was responsible for a larger proportion of NHS expenditure than had previously been reported. Nearly one in five acute hospital admissions were for patients whose condition included cardiac problems. The relation between diabetes and CHD was particularly evident, and may offer opportunities for disease prevention.

Keywords: coronary heart disease;  diabetes mellitus;  cost and cost analysis;  epidemiology

---

© 1997 by Heart
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Currie, C J, Poole, C D, Conway, P (2008). Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 94: 457-462 [Abstract] [Full Text]  
• Bottomley, J., Palmer, A. J, Williams, R., Dormandy, J., Massi-Benedetti, M. (2006). Review: PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular events -- economic implications?. British Journal of Diabetes & Vascular Disease 6: 63-70 [Abstract]  
• Currie, C J, Jones, M, Goodfellow, J, McEwan, P, Morgan, C L, Emmas, C, Peters, J R (2006). Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 92: 196-200 [Abstract] [Full Text]  
• Jones, M, McEwan, P, Morgan, C L., Peters, J R, Goodfellow, J, Currie, C J (2005). Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 91: 472-477 [Abstract] [Full Text]  
• Olveira-Fuster, G., Olvera-Marquez, P., Carral-Sanlaureano, F., Gonzalez-Romero, S., Aguilar-Diosdado, M., Soriguer-Escofet, F. (2004). Excess Hospitalizations, Hospital Days, and Inpatient Costs Among People With Diabetes in Andalusia, Spain. Diabetes Care 27: 1904-1909 [Abstract] [Full Text]  
• Liu, J L Y, Maniadakis, N, Gray, A, Rayner, M (2002). The economic burden of coronary heart disease in the UK. Heart 88: 597-603 [Abstract] [Full Text]  
• Muir, D F, Jummun, M, Stewart, D J, Clark, A L (2002). Diagnostic accuracy of technician supervised and reported exercise tolerance tests. Heart 87: 381-382 [Full Text]  
• Nichols, G. A., Brown, J. B. (2002). The Impact of Cardiovascular Disease on Medical Care Costs in Subjects With and Without Type 2 Diabetes. Diabetes Care 25: 482-486 [Abstract] [Full Text]  
• Grover, S. A., Coupal, L., Zowall, H., Alexander, C. M., Weiss, T. W., Gomes, D. R.J. (2001). How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease?. Diabetes Care 24: 45-50 [Abstract] [Full Text]  
• McAnulty, G. R., Robertshaw, H. J., Hall, G. M. (2000). Anaesthetic management of patients with diabetes mellitus. Br J Anaesth 85: 80-90 [Full Text]  
• RUTTER, M K, MARSHALL, S M, McCOMB, J M (1997). Coronary artery disease and diabetes. Heart 78: 527-529 [Full Text]